Preserving and rebuilding lean muscle is one of the most important predictors of long-term metabolic health
5 This explains why TRIUMPH-4 produced 28.7% weight loss at 68 weeks while STEP-UP produced 20.7% at 72 weeks on Wegovy 7.2 mg, and STEP 1 produced 14.9% at 68 weeks on Wegovy 2.4 mg
Before and after images reflect real patient results, although individual results may vary
While shift work disrupts sleep-wake cycles, melatonin secretion, and natural insulin responses, GLP-1 receptor agonists (such as semaglutide or tirzepatide) introduce sharp caloric deficits, slower digestion, a& temp metabolic adjustments that intensify feelings of tiredness
Reviewed by the PeptideMind Team Updated July 15, 2026 GLP-3 (Retatrutide) Dosage Guide, Benefits & Side Effects This triple GIP/GLP-1/glucagon agonist produced up to 24-29% body weight loss in trials, alongside liver fat, kidney, and cardiovascular improvements
1 Not available in all 50 states